BioPharm News

Oct 10, 2018
Congress approves bills with provisions important to FDA and industry, some of which reflect continuing concerns about drug pricing and transparency.
Oct 10, 2018
By BioPharm International Editors
The companies signed a three-year clinical manufacturing agreement to manufacture GlaxoSmithKline’s specific peptide enhanced affinity receptor T-cell receptor therapy for United States, Canadian, and European clinical trials.
Oct 10, 2018
By BioPharm International Editors
The companies will develop and commercialize ARO-HBV, a Phase I/II subcutaneous, ribonucleic acid interference therapy candidate being investigated for the treatment of chronic hepatitis B viral infection.
Oct 09, 2018
By BioPharm International Editors
The UCL-Pall Biotech Centre of Excellence will address industry challenges and provide workforce training.
Oct 05, 2018
By BioPharm International Editors
The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation to seek views on how legislations and procedures of the agency may need to be modified should there be a ‘no-deal’ Brexit scenario.
Oct 04, 2018
By BioPharm International Editors
Insmed’s Arikayce (amikacin liposome inhalation suspension) is the first drug approved under the agency’s Limited Population Pathway for Antibacterial and Antifungal Drugs, established to support development of antibiotics for unmet medical needs.
Oct 03, 2018
By BioPharm International Editors
The companies will work together to discover, develop, and commercialize immunotherapies for patients with solid-tumor cancers in a collaboration worth $695 million per program.
Oct 01, 2018
FDA is joining with other federal health agencies and the biomedical research community to advance the science, regulatory policies, and reimbursement strategies to support innovation in antimicrobials.
Oct 01, 2018
By BioPharm International Editors
The divestiture of the European generic-drug business of Sanofi—Zentiva—to Advent International has been completed.
Oct 01, 2018
By BioPharm International Editors
Researchers who are younger than 35 years with an advanced degree and working within Europe will be able to apply for the award.
native1_300x100
lorem ipsum